Traumatic brain injury (TBI) is a leading cause of morbidity and disability, with a
considerable socioeconomic burden. Heterogeneity of pathoanatomical subtypes and …

Progressive supranuclear palsy (PSP), previously believed to be a common cause of
atypical parkinsonism, is now recognised as a range of motor and behavioural syndromes …

Accumulation of hyperphosphorylated tau directly correlates with cognitive decline in
Alzheimer's disease and other primary tauopathies. One therapeutic strategy may be to …

Aggregates of the microtubule-associated protein tau are a defining feature of several
neurodegenerative diseases that are collectively known as tauopathies, and constitute one …

There are currently no disease-modifying therapies for the treatment of tauopathies, a group
of progressive neurodegenerative disorders that are pathologically defined by the presence …

Mild traumatic brain injury (mTBI) represents a significant public healthcare concern,
accounting for the majority of all head injuries. While symptoms are generally transient …

The role of microtubule‐associated protein Tau in neurodegeneration has been extensively
investigated since the discovery of Tau amyloid aggregates in the brains of patients with …

Alzheimer's disease (AD) and other neurodegenerative disorders are associated with the
cytoplasmic aggregation of microtubule-associated protein tau. Recent evidence supports …

Traumatic brain injury (TBI) is characterized by acute neurological dysfunction and
associated with the development of chronic traumatic encephalopathy (CTE) and …

Traumatic brain injury (TBI) in women experiencing intimate-partner violence (IPV) is
common, and IPV afflicts 30% of women worldwide. However, the neurobiology and related …